M Meehan

1.0k citations
5 papers · 806 · 1 hit paper · h-index 4

Impact in

Papers in

M Meehan

5 papers receiving 796 citations

M Meehan's Hit Papers

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. 1997 · 691 citations
6910+9+19Years since publication200400600

Peers

M Meehan
Comparison fields: 5 of 50
  • Gastroenterology 172
  • Pulmonary and Respiratory Medicine 712
  • Oncology 415
  • Surgery 402
  • Radiology, Nuclear Medicine and Imaging 55
Replace Keisei Taku with:
Keisei Taku Japan
H J Meyer Germany
Dmitry Bichev Germany
H. Wilke Germany
F Latteri Italy
Vera Oppedijk Netherlands
Toshifumi Kin Japan
G Natalini Italy
Junichiro Nasu Japan
Yoshihide Kanno Japan
M Meehan relative to Keisei Taku Japan Keisei Taku's profile →
Citations per field
00.5×3.4×
Keisei Taku · 1×
Citations per year

Countries citing papers authored by M Meehan

Since Specialization
Citations

This map shows the geographic impact of M Meehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Meehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Meehan more than expected).

Fields of papers citing papers by M Meehan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Meehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Meehan. The network helps show where M Meehan may publish in the future.

Co-authors

The 25 scholars most cited alongside M Meehan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M Meehan Line = papers co-authored together M Meehan links everyone, so they are left out of the graph.

All Works

5 of 5 papers shown
#Work
1
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
Hit paper breakdown →
1997691
2 2000108
3 20013
4
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
19963
5 20031

About M Meehan

M Meehan is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Hepatology, General Health Professions and Oncology, having authored 5 papers that have together received 806 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Lung Cancer Diagnosis and Treatment (1 paper), Palliative Care and End-of-Life Issues (1 paper), Cancer survivorship and care (1 paper), Medical Imaging Techniques and Applications (1 paper), Patient-Provider Communication in Healthcare (1 paper) and Renal Transplantation Outcomes and Treatments (1 paper). The work is most often cited by research in Gastroenterology (172 citations), Pulmonary and Respiratory Medicine (712 citations), Oncology (415 citations), Surgery (402 citations) and Radiology, Nuclear Medicine and Imaging (55 citations). M Meehan has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include J.H. Scarffe, Andrew Wardley, MC Nicolson, Tamas Hickish, Janine Mansi, Peter Harper, M Findlay, Matthew Watson, Mary O’Brien and J. Oates. Their work appears in journals such as Journal of Clinical Oncology, Hepatology, Clinical Nuclear Medicine, European Journal of Cancer Care and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact